Bottom line
FBIOX vs FBT: the short answer
FBIOX (Biotechnology Portfolio) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are both mutual funds.
But FBIOX is far broader, holding 215 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.
FBT is cheaper at 0.55% vs 0.62% — a difference of $7.00 a year per $10,000 invested.
Over five years, FBT returned +4.3% a year vs +3.5% for FBIOX (reporting dates differ).
Updated Nov 19, 2026
FBIOX vs FBT side by side
| FBIOX | FBT | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | First Trust |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.62% | 0.55% |
| Annual cost per $10k | $62 | $55 |
| 10-yr cost on $10k (prospectus) | $774 | — |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +36.4% | +24.1% |
| 5-yr return (annualized) | +3.5% | +4.3% |
| 10-yr return (annualized) | +6.9% | +6.3% |
| Best quarter | +33.6% | +27.8% |
| Worst quarter | −28.4% | −22.5% |
| Net assets (fund) | $5.3B | $2.8B |
| Number of holdings | 215 | 32 |
| Portfolio turnover | 45% | 37% |
| Returns as of | Apr 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FBIOX | FBT | Difference |
|---|---|---|---|
| 2025 | +36.4% | +24.1% | +12.3% |
| 2024 | +7.3% | +5.8% | +1.5% |
| 2023 | +10.1% | +2.3% | +7.8% |
| 2022 | −15.9% | −4.6% | −11.3% |
| 2021 | −12.4% | −3.6% | −8.7% |
| 2020 | +38.3% | +12.9% | +25.4% |
| 2019 | +36.0% | +19.8% | +16.2% |
| 2018 | −10.7% | −0.2% | −10.5% |
| 2017 | +27.9% | +37.0% | −9.1% |
| 2016 | −23.7% | −19.6% | −4.1% |
Source: Fund prospectus bar charts
Holdings overlap
7 of FBIOX's top 25 holdings also appear in FBT's top 25.
| Holding | FBIOX | FBT |
|---|---|---|
| Krystal Biotech Inc | 10.58% | 3.87% |
| Amgen Inc | 6.53% | 2.78% |
| Alnylam Pharmaceuticals Inc | 2.93% | 2.52% |
| Argenx Se | 2.25% | 3.13% |
| Natera Inc | 1.41% | 3.79% |
| Axsome Therapeutics Inc | 1.28% | 3.71% |
| Biogen Inc | 1.26% | 3.37% |
Source: SEC Form N-PORT
FBIOX top 10
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Amgen Inc — 6.53%
- Gilead Sciences Inc — 4.82%
- Fidelity Revere Street Trust — 3.35%
- Alnylam Pharmaceuticals Inc — 2.93%
- Praxis Precision Medicines Inc. — 2.47%
- Insmed Inc — 2.25%
- Argenx Se — 2.25%
- Ascendis Pharma A/s — 2.04%
FBT top 10
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Illumina Inc — 3.92%
- Krystal Biotech Inc — 3.87%
- Natera Inc — 3.79%
- Axsome Therapeutics Inc — 3.71%
- Neurocrine Biosciences Inc — 3.53%
FAQ
What is the difference between FBIOX and FBT?
Which is cheaper, FBIOX or FBT?
Should I own both FBIOX and FBT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.